Get the Stockscreener App
144.01
0.60%
-0.78
Overview
News
Price History
Option Chain
Financials
Why ORCL Down?
Discussions
Forecast
Stock Split
Dividend History
Oracle Corp stock is traded at $144.01, with a volume of 14.94M.
It is down -0.60% in the last 24 hours and down -4.38% over the past month.
Oracle provides enterprise applications and infrastructure offerings through a variety of flexible IT deployment models, including on-premises, cloud-based, and hybrid. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system, which is commonly used by the world's largest companies for high-volume online transaction processing workloads. Besides databases, Oracle also sells enterprise resource planning platforms and cloud infrastructure that play an increasingly important role in large language model training and inferencing.
See More
Previous Close:
$144.79
Open:
$143.46
24h Volume:
14.94M
Relative Volume:
0.47
Market Cap:
$414.76B
Revenue:
$67.36B
Net Income/Loss:
$17.31B
P/E Ratio:
24.72
EPS:
5.8248
Net Cash Flow:
$-23.69B
1W Performance:
-11.44%
1M Performance:
-4.38%
6M Performance:
-7.21%
1Y Performance:
-52.37%
1-Day Range:
$140.41
$144.88
1-Week Range:
$140.41
$166.00
52-Week Range:
$114.50
$329.50
Oracle Corp Stock (ORCL) Company Profile
Name
Oracle Corp
Sector
Industry
Phone
(737) 867-1000
Address
2300 ORACLE WAY, AUSTIN, CA
Compare ORCL vs MSFT, PLTR, CRWD, FTNT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ORCL
Oracle Corp
|
143.99 | 432.88B | 67.36B | 17.31B | -23.69B | 5.8248 |
MSFT
Microsoft Corp
|
501.14 | 3.68T | 318.27B | 125.22B | 72.92B | 16.79 |
PLTR
Palantir Technologies Inc
|
172.92 | 401.86B | 5.22B | 2.29B | 2.69B | 0.8876 |
CRWD
Crowdstrike Holdings Inc
|
240.54 | 211.69B | 5.09B | -24.89M | 1.43B | -0.0471 |
FTNT
Fortinet Inc
|
170.50 | 114.51B | 7.11B | 1.95B | 2.44B | 2.5883 |
Oracle Corp Stock (ORCL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-20-26 | Initiated | CLSA | Hold |
| Jun-11-26 | Reiterated | BMO Capital Markets | Outperform |
| May-12-26 | Reiterated | Oppenheimer | Outperform |
| May-07-26 | Upgrade | Arete | Neutral → Buy |
| Apr-24-26 | Initiated | Wedbush | Outperform |
| Apr-10-26 | Downgrade | Cleveland Research | Buy → Neutral |
| Mar-24-26 | Resumed | BofA Securities | Buy |
| Mar-11-26 | Reiterated | BMO Capital Markets | Outperform |
| Mar-11-26 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-11-26 | Reiterated | Oppenheimer | Outperform |
| Feb-25-26 | Upgrade | Oppenheimer | Perform → Outperform |
| Feb-09-26 | Upgrade | DA Davidson | Neutral → Buy |
| Feb-09-26 | Downgrade | Melius | Buy → Hold |
| Feb-04-26 | Reiterated | BMO Capital Markets | Outperform |
| Jan-12-26 | Resumed | Goldman | Buy |
| Dec-11-25 | Reiterated | BMO Capital Markets | Outperform |
| Dec-03-25 | Initiated | Wells Fargo | Overweight |
| Nov-10-25 | Downgrade | Erste Group | Buy → Hold |
| Oct-13-25 | Reiterated | BMO Capital Markets | Outperform |
| Oct-09-25 | Initiated | Robert W. Baird | Outperform |
| Sep-25-25 | Initiated | Rothschild & Co Redburn | Sell |
| Sep-10-25 | Reiterated | BMO Capital Markets | Outperform |
| Sep-10-25 | Upgrade | BofA Securities | Neutral → Buy |
| Sep-10-25 | Upgrade | Citigroup | Neutral → Buy |
| Sep-09-25 | Reiterated | BMO Capital Markets | Outperform |
| Jul-17-25 | Initiated | Scotiabank | Sector Outperform |
| Jul-10-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jul-02-25 | Reiterated | BMO Capital Markets | Outperform |
| Jun-30-25 | Upgrade | Stifel | Hold → Buy |
| Jun-18-25 | Reiterated | Guggenheim | Buy |
| Jun-13-25 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Jun-09-25 | Reiterated | BMO Capital Markets | Market Perform |
| Apr-23-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Mar-19-25 | Initiated | Stephens | Equal-Weight |
| Mar-11-25 | Reiterated | BMO Capital Markets | Market Perform |
| Mar-03-25 | Upgrade | Monness Crespi & Hardt | Sell → Neutral |
| Jan-17-25 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-20-24 | Downgrade | Monness Crespi & Hardt | Neutral → Sell |
| Oct-23-24 | Initiated | RBC Capital Mkts | Sector Perform |
| Sep-16-24 | Upgrade | Melius | Hold → Buy |
| Sep-10-24 | Reiterated | BMO Capital Markets | Market Perform |
| Sep-10-24 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Jun-17-24 | Reiterated | BMO Capital Markets | Market Perform |
| Apr-18-24 | Initiated | Oppenheimer | Perform |
| Mar-21-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Mar-14-24 | Upgrade | Argus | Hold → Buy |
| Mar-12-24 | Reiterated | BMO Capital Markets | Market Perform |
| Mar-12-24 | Upgrade | William Blair | Mkt Perform → Outperform |
| Dec-12-23 | Reiterated | BMO Capital Markets | Market Perform |
| Nov-13-23 | Upgrade | Edward Jones | Hold → Buy |
| Oct-09-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Sep-15-23 | Initiated | HSBC Securities | Buy |
| Sep-14-23 | Upgrade | DZ Bank | Hold → Buy |
| Sep-13-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-12-23 | Downgrade | Monness Crespi & Hardt | Buy → Neutral |
| Sep-05-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-29-23 | Upgrade | UBS | Neutral → Buy |
| Jun-13-23 | Upgrade | Goldman | Sell → Neutral |
| Jun-12-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Apr-20-23 | Reiterated | KeyBanc Capital Markets | Overweight |
| Mar-10-23 | Downgrade | Societe Generale | Buy → Hold |
| Jan-18-23 | Initiated | DA Davidson | Neutral |
| Jan-11-23 | Initiated | Mizuho | Buy |
| Jan-09-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-05-23 | Upgrade | Jefferies | Hold → Buy |
| Oct-21-22 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Oct-20-22 | Upgrade | Piper Sandler | Underweight → Neutral |
| Sep-14-22 | Initiated | Berenberg | Hold |
| Aug-12-22 | Initiated | Guggenheim | Buy |
| Jun-29-22 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Jun-27-22 | Resumed | Goldman | Sell |
| Jun-14-22 | Reiterated | Monness Crespi & Hardt | Buy |
| Apr-01-22 | Initiated | Daiwa Securities | Neutral |
| Mar-29-22 | Downgrade | Exane BNP Paribas | Neutral → Underperform |
| Mar-11-22 | Downgrade | Piper Sandler | Neutral → Underweight |
| Mar-11-22 | Upgrade | Societe Generale | Hold → Buy |
| Dec-21-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Dec-15-21 | Upgrade | DZ Bank | Sell → Hold |
| Dec-10-21 | Reiterated | BMO Capital Markets | Market Perform |
| Dec-10-21 | Reiterated | Barclays | Equal Weight |
| Dec-10-21 | Reiterated | Citigroup | Neutral |
| Dec-10-21 | Reiterated | Cowen | Outperform |
| Dec-10-21 | Upgrade | Deutsche Bank | Hold → Buy |
| Dec-10-21 | Reiterated | Monness Crespi & Hardt | Buy |
| Dec-10-21 | Reiterated | Piper Sandler | Neutral |
| Dec-10-21 | Reiterated | Societe Generale | Hold |
| Dec-10-21 | Reiterated | Stifel | Hold |
| Dec-10-21 | Reiterated | UBS | Neutral |
| Dec-10-21 | Reiterated | Wolfe Research | Peer Perform |
| Nov-16-21 | Initiated | Credit Suisse | Outperform |
| Nov-02-21 | Initiated | Deutsche Bank | Hold |
| Sep-14-21 | Reiterated | BMO Capital Markets | Market Perform |
| Sep-14-21 | Reiterated | Monness Crespi & Hardt | Buy |
| Aug-10-21 | Downgrade | DZ Bank | Hold → Sell |
| May-10-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Apr-23-21 | Initiated | Wolfe Research | Peer Perform |
| Apr-21-21 | Downgrade | DZ Bank | Buy → Hold |
| Apr-01-21 | Resumed | Wedbush | Neutral |
| Mar-22-21 | Resumed | Evercore ISI | In-line |
| Mar-16-21 | Resumed | Credit Suisse | Outperform |
| Mar-11-21 | Reiterated | Monness Crespi & Hardt | Buy |
| Mar-11-21 | Downgrade | Societe Generale | Buy → Hold |
| Mar-05-21 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-03-21 | Resumed | Citigroup | Neutral |
| Jan-22-21 | Initiated | Goldman | Sell |
| Dec-18-20 | Upgrade | Monness Crespi & Hardt | Neutral → Buy |
| Dec-16-20 | Resumed | BofA Securities | Neutral |
| Dec-08-20 | Downgrade | Cleveland Research | Buy → Neutral |
| Nov-24-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-14-20 | Resumed | UBS | Neutral |
| Sep-21-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Sep-11-20 | Reiterated | BMO Capital Markets | Market Perform |
| Sep-11-20 | Reiterated | Barclays | Equal Weight |
| Sep-11-20 | Reiterated | Credit Suisse | Outperform |
| Sep-11-20 | Reiterated | Goldman | Buy |
| Sep-11-20 | Reiterated | Jefferies | Hold |
| Sep-11-20 | Reiterated | Morgan Stanley | Equal-Weight |
| Sep-11-20 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-11-20 | Reiterated | Stifel | Hold |
| Sep-11-20 | Reiterated | Wells Fargo | Overweight |
| Jun-19-20 | Downgrade | Argus | Buy → Hold |
| Jun-01-20 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| Mar-31-20 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Mar-20-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-13-20 | Reiterated | BMO Capital Markets | Market Perform |
View All
Oracle Corp Stock (ORCL) Latest News
Ellison Cancels Plan to Sell 50M Oracle Shares - Briefs Finance
Larry Ellison Cancels $7.5 Billion Oracle Stock Sale - stl.news
Weekend Round-Up: Nvidia's Bold Claims, Oracle's Earnings Pop and Apple's New iPhone Launches - TradingView
Larry Ellison scraps $7.5 billion Oracle stock sale one day after it became public - CryptoRank
Oracle layoffs: IT giant adds $700 million to restructuring tally amid expensive AI push - businesstoday.in
Oracle’s Larry Ellison Cancels 50M-Share Sale Amid Mixed Analyst ViewsOracle (NYSE:ORCL) - Benzinga
Larry Ellison cancels plan to sell Oracle stock - Honolulu Star-Advertiser
Larry Ellison cancels plan to sell Oracle stock By Reuters - Investing.com
Oracle’s Ellison cancels plan to sell up to 50 mln shares - investing.com
Oracle’s Larry Ellison cancels plan to sell up to 50 million shares - Moneycontrol.com
Larry Ellison Ends Plan to Sell Up to $7.5 Billion in Oracle Stock - Bloomberg.com
Larry Ellison cancels $7.5bn Oracle share sale - Financial Times
Larry Ellison nixes plan to offload up to $7.5 billion worth of Oracle stock - CNBC
Oracle Stock Still Burns Cash After Ellison Cancels $7.5 Billion Sale - Forbes
Oracle Raises Layoff Cost Amid AI Buildout - Briefs Finance
Jim Cramer on Oracle: $664B Backlog Signals Major Shift in Company’s Growth Trajectory - Yahoo Finance
GameStop, Oracle, Apple and More: Five Stocks Investors Couldn't Stop Buzzing About This Week - Benzinga
ORCL Stock Soars 7% After-Hours — Oracle Cloud Surge Powers Q1 Beat As AI Demand Fuels Record Backlog - Stocktwits
Oracle Just Added $30 Billion in AI Contracts. Nvidia Investors Should Read the Fine Print - Yahoo Finance
Oracle layoffs: More job cuts expected as company faces rising AI data centre costs - firstpost.com
Monster $7.5 billion insider trading alert for Oracle stock - finbold.com
Oracle's backlog hit $664 billion. It sold $20 billion of stock to build it - techi.com
Oracle to spend an additional US$700 million on more job cuts - The Business Times
Oracle to spend an additional $700m on more job cuts - chinadailyasia.com
Oracle: You Didn't Miss It, There's Still 40% Upside (NYSE:ORCL) - Seeking Alpha
Oracle raises spending on workforce cuts by $700 million — NDTV World - UA.NEWS
Oracle To Spend Another $700 Million On Job Cuts Amid AI-Led Cash Crunch - NDTV
Oracle Plans More Job Cuts, Adds $700 Million To Restructuring Costs Amid AI Spending - ndtvprofit.com
Oracle Adds $700 Million to Restructuring Bill as AI Data Center Spending Strains Cash Flow - finance.biggo.com
ORACLE CORP DEPOSITARY SH REP 1/2000TH PFD SER D To Go Ex-Dividend On October 1st, 2026 With 0.8125 USD Dividend Per Share - 富途牛牛
How To Earn $500 A Month From Oracle Stock Ahead Of Q1 Earnings - Yahoo Finance
Oracle's Larry Ellison adopts trading plan to sell up to $7.5 billion worth of stock - CNBC
Oracle (ORCL)’s Licensing Terms Draw the Same EU Scrutiny that Just Cost SAP Concessions - Yahoo Finance
Oracle to Spend an Additional $700 Million on More Job Cuts - Bloomberg.com
Oracle to spend $700 million more on restructuring costs as it ramps up AI spending - Reuters
Oracle Reportedly Expands Restructuring Plan by $700M As AI Data Center Costs Mount - Yahoo Finance
Larry Ellison to sell up to $7.5bn worth of Oracle stock - Financial Times
Oracle Just Showed a Less Painful Way to Finance AI Clouds. That’s Awkward for CoreWeave - Yahoo Finance
Oracle Is Spending Tens of Billions on AI Infrastructure. Where Does the Physical Money Go? - Yahoo Finance
Oracle (ORCL) Stock Faces AI Funding Questions After Profit Surge - simplywall.st
Oracle reveals $700M in additional restructuring costs tied to layoffs - Seeking Alpha
Larry Ellison Steps Back From Oracle Limelight in AI Era - Bloomberg.com
Oracle Says Its Expiring AI Contracts Are Renewing 20% Higher - The Globe and Mail
BMO Tweaks Oracle Stock Price Target After AI Risk - Yahoo Finance UK
Stocks Rise as Oil Drops, Oracle Boosts Tech - Briefs Finance
Oracle shook off fears about AI spending, but its stock still loses ground - MarketWatch
ORACLE CORP Q1 2027: Revenue $19.35B, EPS $1.56— 10-Q Summary - TradingView
Cloud push lifts Oracle (NYSE: ORCL) as infrastructure revenue more than doubles and data center spending jumps - Stock Titan
Oracle's East Bank oasis: Where the public can and can't go - The Business Journals
Oracle cloud revenue more than doubles as AI demand drives growth - Austin American-Statesman
Oracle Corporation : RBC gives a Neutral rating - marketscreener.com
Oracle Corp Stock (ORCL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.86%
1.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):